(Q48858572)

English

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.

scientific article published in November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

1

object named as

A Kupsch

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

2

object named as

J Sautter

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

3

object named as

J Schwarz

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

4

object named as

P Riederer

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

Wolfgang H. Oertel

6

object named as

W H Oertel

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

author name string

Gerlach M

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

741

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

1-2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

185-196

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Evidence for retrograde axonal transport of MPP+ in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/Bl6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

K(+)-evoked dopamine release depends on a cytosolic Ca2+ pool regulated by N-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Nimodipine enhances growth and vascularization of neural grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Effect of the Calcium Antagonist, Nimodipine, on Cerebral Blood Flow and Metabolism in the Primate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

MPTP toxicity: implications for research in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

The effect of nimodipine on high-energy phosphates and intracellular pH during cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Movement disorders and depression due to flunarizine and cinnarizine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

[3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium io

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Flunarizine induces a transient loss of tyrosine hydroxylase immunoreactivity in nigrostriatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Effects of Brain-derived Neurotrophic Factor on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900917-1

7 January 2021

Identifiers

10.1016/S0006-8993(96)00917-1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/9001722

Semantic Scholar paper ID

bad555f62e3924175b5d9273e97b04fd4594f909

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48858572&oldid=2081739101"